What is lecanemab and how does it slow down Alzheimer's disease?

Update: 2025-11-06

Description

A new Health Canada-approved drug called lecanemab has been shown to slow early-stage Alzheimer's disease. Neurologist Dr. Sharon Cohen, who participated in phase three trials for the drug, explains why lecanemab is such a big deal.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Comments

In Channel

What should you do if you think you have Omicron?

2022-01-0523:07

How do I take back control in this never-ending pandemic?

2021-12-2221:59

How much should Omicron affect our holiday plans?

2021-12-1523:10

What do we need to know now about third doses of COVID vaccines?

2021-12-0822:53

What do we need to know about the omicron variant?

2021-12-0222:23

How can we make vaccinations less painful for kids?

2021-11-2524:44

What's safe this fall when it comes to indoor activities?

2021-11-1122:52

What's the latest in flu vaccines?

2021-10-2822:36

What’s the latest in treatments for COVID-19?

2021-10-0722:48

If it's not Covid, what is it?

2021-09-2323:51

Who needs a third shot and why?

2021-09-1622:22

How can you use science to talk to someone you know who is vaccine hesitant?

2021-09-0922:53

Can we avoid a lockdown this fall?

2021-09-0222:19